Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection
Author:
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical)
Link
http://link.springer.com/content/pdf/10.1007/s40121-014-0050-x
Reference28 articles.
1. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431–55.
2. Moudgal V, Sobel JD. Clostridium difficile colitis: a review. Hosp Pract (1995). 2012;40(1):139–48.
3. Adams SD, Mercer DW. Fulminant Clostridium difficile colitis. Curr Opin Crit Care. 2007;13(4):450–5.
4. Bartlett JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med. 2006;145(10):758–64.
5. Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States. 2013. p. 55–9. http://www.cdc.gov/drugresistance/threat-report-2013/
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Retrospective Analysis of the Clinical Effectiveness of Tigecycline in the Treatment of Clostridioides difficile-Associated Diarrhea;Pharmacoepidemiology;2024-06-13
2. In vitro Activity of Dalbavancin and Fourteen Other Antimicrobial Agents against Toxigenic <i>Clostridioides difficile</i> Clinical Isolates in a Greek Tertiary-Care Hospital;Medical Principles and Practice;2024
3. Systematic review of guidelines for the diagnosis and treatment of Clostridioides difficile infection;Frontiers in Cellular and Infection Microbiology;2022-08-30
4. Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection;Seminars in Respiratory and Critical Care Medicine;2022-02
5. Clostridioides difficile Infection, Still a Long Way to Go;Journal of Clinical Medicine;2021-01-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3